NMTC: NeuroOne Medical Technologies Corporation Stock

by  •  • Comments Off on NMTC: NeuroOne Medical Technologies Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 29.43
Enterprise Value ($M) 28.30
Book Value ($M) 2.94
Book Value / Share 0.06
Price / Book 10.03
NCAV ($M) 2.15
NCAV / Share 0.05
Price / NCAV 13.67

Profitability (mra)
Return on Invested Capital (ROIC) -2.19
Return on Assets (ROA) -1.33
Return on Equity (ROE) -1.86

Liquidity (mrq)
Quick Ratio 2.41
Current Ratio 3.64

Balance Sheet (mrq) ($M)
Current Assets 5.71
Assets 6.49
Liabilities 3.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.45
Operating Income -11.89
Net Income -12.32
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Reconciliation Disclosure n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.01
Cash from Investing -0.12
Cash from Financing 7.27

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Manchester Management Co Llc 4.90 -35.06
02-04 13G/A Merchant Adventure Fund, L.p. 13.60
11-25 13G/A Lytton Laurence W 6.60 57.96
11-14 13G/A Nantahala Capital Management, LLC 2.60 -34.21
11-14 13G/A AWM Investment Company, Inc. 7.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2024 ☐ TRANSITION REPORT
2024-12-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 ☐ TRANSITION REPORT PURSUAN
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2024 ☐ TRANSITION REPORT PURS
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 ☐ TRANSITION REPORT PUR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 68,821 152,586 45.10
2025-04-28 24,314 152,877 15.90
2025-04-25 122,950 312,335 39.36
2025-04-24 316,948 958,152 33.08

(click for more detail)

Similar Companies
NAOV – NanoVibronix, Inc. NDRA – ENDRA Life Sciences Inc.
NEPH – Nephros, Inc. NSPR – InspireMD, Inc.
NTRB – Nutriband Inc.


Financial data and stock pages provided by
Fintel.io